* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Integra Lifesciences Holdings's PEG Ratio or its related term are showing as below:
IART'
s PEG Ratio Range Over the Past 10 Years
Min: 0.91 Med: 4.67 Max: 745.11
Current: 1.32
During the past 13 years, Integra Lifesciences Holdings's highest PEG Ratio was 745.11. The lowest was 0.91. And the median was 4.67.
IART's PEG Ratio is ranked better than 60.32% of 247
companies
in the Medical Devices & Instruments industry
Industry Median: 1.79
vs IART: 1.32
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Integra Lifesciences Holdings PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Integra Lifesciences Holdings's PEG Ratio
For the Medical Devices subindustry, Integra Lifesciences Holdings's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integra Lifesciences Holdings's PEG Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Integra Lifesciences Holdings's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Integra Lifesciences Holdings's PEG Ratio falls into.
Integra Lifesciences Holdings PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Integra Lifesciences Holdings (NAS:IART) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Integra Lifesciences Holdings PEG Ratio Related Terms
Thank you for viewing the detailed overview of Integra Lifesciences Holdings's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Integra Lifesciences Holdings (Integra Lifesciences Holdings) Business Description
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IART has been successfully added to your 